TickerFacts.

DaVita Inc. (DVA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.76B
Year ended 2025-12-31
$2.84B
Trailing 12 months to 2026-06-30
+10.0%
3-year compound annual growth
+3.5%
5-year compound annual growth
+5.6%
10-year compound annual growth
$2.81B2007-12-31: $1.10B2008-12-31: $1.09B2009-12-31: $1.17B2010-12-31: $1.23B2011-12-31: $1.42B2012-12-31: $1.64B2013-12-31: $2.08B2014-12-31: $2.41B2015-12-31: $1.60B2016-12-31: $2.54B2017-12-31: $2.37B2018-12-31: $2.12B2019-12-31: $2.26B2020-12-31: $2.33B2021-12-31: $2.48B2022-12-31: $2.07B2023-12-31: $2.35B2024-12-31: $2.81B2025-12-31: $2.76B$2.76B
2007-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$2.76B-2.0%2026-02-11, From 2025-01-01
2024-12-31$2.81B+19.8%2026-02-11, From 2024-01-01
2023-12-31$2.35B+13.3%2026-02-11, From 2023-01-01
2022-12-31$2.07B-16.4%2025-02-13, From 2022-01-01
2021-12-31$2.48B+6.6%2024-02-14, From 2021-01-01
2020-12-31$2.33B+2.9%2023-02-22, From 2020-01-01
2019-12-31$2.26B+6.7%2022-02-11, From 2019-01-01
2018-12-31$2.12B-10.8%2021-02-12, From 2018-01-01
2017-12-31$2.37B-6.6%2020-02-21, From 2017-01-01
2016-12-31$2.54B+58.6%2019-02-22, From 2016-01-01
2015-12-31$1.60Bn/c2018-02-23, From 2015-01-01
2014-12-31$2.41B+15.7%2017-02-24, From 2014-01-01
2013-12-31$2.08B+26.8%2016-02-26, From 2013-01-01
2012-12-31$1.64B+15.5%2015-02-26, From 2012-01-01
2011-12-31$1.42B+15.8%2014-02-21, From 2011-01-01
2010-12-31$1.23B+4.9%2013-03-01, From 2010-01-01
2009-12-31$1.17B+7.6%2012-02-24, From 2009-01-01
2008-12-31$1.09B-1.5%2011-02-25, From 2008-01-01
2007-12-31$1.10Bn/a2010-02-25, From 2007-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
DaVita Inc. (DVA)2025-12-31$2.76B-2.0%
agilon health, inc. (AGL)2025-12-31-$434.64Mn/m
Progyny, Inc. (PGNY)2025-12-31$90.22M+27.7%
Sotera Health Co (SHC)2024-12-31$381.93M+8.1%
Viemed Healthcare, Inc. (VMD)2025-12-31$51.56M+19.2%
Cryo Cell International Inc (CCEL)2025-11-30$1.23M-68.9%
Marpai, Inc. (MRAI)2025-12-31-$13.17Mn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$1.03M+15.6%
Mangoceuticals, Inc. (MGRX)2024-12-31-$7.96Mn/m

Compare DVA, AGL, PGNY, SHC side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗